Follow us on Twitter
twitter icon@FreshPatents


Staurosporine patents

      

This page is updated frequently with new Staurosporine-related patent applications.




Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of mll rearranged all; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of mll rearranged all.. .

Plymorephous forms iii and iv of n-benzoyl - staurosporine
The present invention relates to a crystalline form iii and a crystalline form iv of n-benzoyl staurosporine.. .

Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of mll rearranged all; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of mll rearranged all.. .

Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
The present invention relates to a method of treating a warm-blooded animal, especially a human, having mixed lineage leukemia (mll rearranged all) comprising administering to said animal a therapeutically effective amount of a staurosporine derivative, especially pkc412 or a pharmaceutically acceptable salt thereof, alone or in combination with further therapeutic measures, for example, those defined herein; to the use of a staurosporine derivative for the preparation of a medicament for the treatment of mll rearranged all; and to a commercial package comprising a staurosporine derivative together with instructions for its use in the treatment of mll rearranged all.. .

Spontaneously dispersible n-benzoyl staurosporine compositions
Spontaneously dispersible n-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of n-benzoyl-staurosporine, as well as their preparation and use in medical treatment.. .



Staurosporine topics:
  • Staurosporine
  • Staurosporin
  • Sudden Infant Death
  • Prophylactic
  • Sudden Infant Death Syndrome
  • Therapeutical
  • Allergic Rhinitis
  • Multiple Sclerosis
  • Aspergillosis
  • Angioedema
  • Mastocytosis
  • Bronchopulmonary
  • Dermatitis
  • Food Allergy
  • Effective Dose


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Staurosporine for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Staurosporine with additional patents listed. Browse our RSS directory or Search for other possible listings.


    6.8293

    file didn't exist246

    479197 - 0 - 5